Phase 2 Refractory Classic Hodgkin Lymphoma Clinical Trials

2 recruitingPhase 2

What is a Phase 2 trial?

Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.

Showing 1–2 of 2 trials

Recruiting

Phase 2

Brentuximab Vedotin and Nivolumab for the Treatment of Relapsed/Refractory Classic Hodgkin Lymphoma Previously Treated With Brentuximab Vedotin or Checkpoint Inhibitors

Recurrent Classic Hodgkin LymphomaRefractory Classic Hodgkin Lymphoma

Emory University46 enrolled2 locationsNCT05039073

Recruiting

Phase 2

Azacitidine Plus PD-1 Therapy for R/R Hodgkin Lymphoma

Refractory Classic Hodgkin LymphomaRelapsed Classic Hodgkin Lymphoma

Navy General Hospital, Beijing40 enrolled1 locationNCT06190067